|
2023
|
Invention
|
Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors.
The inven... |
|
2021
|
Invention
|
Methods of use for single molecule compounds providing multi-target inhibition to treat covid 19.... |
|
|
Invention
|
Methods of use for single molecule compounds providing multi-target inhibition to treat covid-19.... |
|
2019
|
Invention
|
Single molecule compounds providing multi-target inhibition of btk and other proteins and methods... |
|
2018
|
Invention
|
Single molecule compounds providing multi-target inhibition of parp and other proteins and method... |
|
|
Invention
|
Thienopyranones and furanopyranones as checkpoint inhibitors and modulators of anti-tumor immunit... |
|
|
Invention
|
Thienopyranones and furanopyranones as checkpoint inhibitors and modulatiors of anti-tumor immuni... |
|
|
Invention
|
Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors. The invent... |
|
2017
|
Invention
|
Thienopyranones as kinase and epigenetic inhibitors. The invention relates to methods of treating... |
|
2016
|
Invention
|
Thienopyranones as kinase inhibitors. The invention relates to compounds of formula I (or pharmac... |
|
|
Invention
|
Thienopyranones as kinase and epigenetic inhibitors.
The invention relates to methods of treatin... |
|
2015
|
Invention
|
Heterocyclic compound classes for signaling modulation. The invention relates to compounds of For... |
|
2009
|
Invention
|
Thienopyranones as kinase inhibitors. The invention, relates to compounds of formula I (or pharma... |
|
2007
|
Invention
|
Pi-3 kinase inhibitor prodrugs. The invention provides novel prodrugs of inhibitors of PI-3 kinas... |
|
2006
|
Invention
|
Mitogen-activated protein kinase kinase mek6 and methods of use thereof.
Compositions and method... |
|
2005
|
Invention
|
Pi-3 kinase inhibitor prodrugs. The invention provides prodrugs of inhibitors of PI-3 kinase. The... |
|
2004
|
Invention
|
Mitogen-activated protein kinase kinase mek6 and methods of use therefor.
Compositions and metho... |
|
|
Invention
|
Pns cell lines and methods of use therefor.
Conditionally-immortalized PNS progenitor cell lines... |
|
|
Invention
|
Human mesencephalon cell lines and methods of use therefor.
Conditionally-immortalized human mes... |
|
|
Invention
|
Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms.
Th... |
|
|
Invention
|
Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms. The... |
|
2003
|
Invention
|
Compounds useful for the treatment of cancer, compositions thereof and methods therewith. The pre... |
|
|
Invention
|
Substituted diaminopyrimidines. The invention relates to substituted diaminopyrimidine compounds,... |
|
|
Invention
|
Methods for using jnk inhibitors for treating or preventing disease-related wasting. The present ... |
|
|
Invention
|
Benzopyranone compounds, compositions thereof, and methods of treatment therewith. Benzopyranone ... |
|
|
Invention
|
Mitogen-activated protein kinase mek6 and methods of use therefor. Compositions and methods are p... |
|
|
Invention
|
Combination therapy for treating, preventing or managing proliferative disorders and cancers. The... |
|
2002
|
Invention
|
Methods for modulating signal transduction mediated by tgf-beta related proteins. Methods are pro... |
|
|
Invention
|
Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis. Th... |
|
|
Invention
|
Markers for evaluating estrogenic activity. Methods are provided for evaluating estrogenic and an... |
|
|
Invention
|
Benzopyrazone compounds, compositions thereof, and methods of treatment therewith. Benzopyranone ... |
|
|
Invention
|
Anthrone derivatives and their use as ink inhibitors. Isothiazoloanthrones, isoxazoloanthrones, i... |
|
2001
|
Invention
|
Stimulus-inducible protein kinase complex and methods of use therefor. Compositions and methods a... |
|
|
Invention
|
Compounds and methods for modulating activation of nf-κb. Compositions and methods for modulating... |
|
2000
|
Invention
|
Mitogen-activated protein kinase p38-2 and methods of use therefor. Compositions and methods are ... |
|
|
Invention
|
Compounds and methods for modulation of estrogen receptors. Compounds that modulate the estrogen ... |
|
1999
|
Invention
|
Method for the affinity isolation of newly synthesized rna. Methods are provided for the isolatio... |
|
1998
|
Invention
|
Pns cell lines and methods of use therefor. Conditionally-immortalized PNS progenitor cell lines ... |
|
1996
|
Invention
|
Human cns cell lines and methods of use therefor. Conditionally-immortalized human CNS progenitor... |
|
1992
|
Invention
|
Method and composition for inhibition of viral replication. A method and pharmaceutical compositi... |
